ARCA biopharma ABIO jumped 38.89% to $2.50 after the company announced the FDA acceptance of Gencaro companion diagnostic test IDE.
NuPathe PATH rose 34.67% to $4.35 after the company received an offer of $3.65 per share from Teva Pharmaceutical Industries TEVA.
Dataram DRAM moved up 30.26% to $3.4128. Dataram shares have gained 1.16% over the past 52 weeks, while the S&P 500 index has surged 25.79% in the same period.
XTL Biopharmaceuticals XTLB shares jumped 16.04% to $3.17 after the company signed a licensing agreement with Yeda Research and Development Company to develop hCDR1.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in